TGX-221 T2661
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
TGX-221, an effective, specific, and cell membrane permeable inhibitor of the PI3K p110_ catalytic subunit, is utilized for cancer treatment.
CAS nr:
663619-89-4
Purity:
98%
Molecular Weight:
364,44
SMILES:
CC(Nc1ccccc1)c1cc(C)cn2c(=O)cc(nc12)N1CCOCC1
Formula:
C21H24N4O2
Pathway:
PI3K/Akt/mTOR signaling
Target:
PI3K
